Clinical Trial Update: RSV Vaccination in Immunocompromised Patients. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating an RSV vaccine in immunocompromised patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• RSV vaccine (Phase 2 trial)

Snippet

Sponsor: Medical University of Vienna | Conditions: RSV Infection | Phase 2 | Status: RECRUITING